Patent · US Active

Use of alginate oligomers as blood anticoagulants

US11712448B2 · kind B2 · utility

0Cited by

5References

35Claims

0Family size

Assignee

AlgiPharma AS · NO

Inventors

Arne Dessen · Røyken, NO
Philip Rye · Oslo, NO

Key dates

Filing date	Dec 19, 2014
Grant date	Aug 1, 2023
Priority date	—
Expiry date	Dec 19, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to an alginate oligomer of 2 to 75 monomer residues, wherein said monomer residues do not carry a sulphate group, for use as a blood anticoagulant in clinical and non-clinical applications, including in vivo, ex vivo and in vitro contexts. The invention further provides for the use of such an alginate oligomer in preparing a product or device having a reduced capacity to promote blood coagulation, wherein said alginate oligomer is provided at or on a surface of said product or device. Such products and devices form a further aspect of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.